PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma.
Ki67
apoptosis
cancer
cell cycle
melanoma
podoplanin
squamous cell carcinoma
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
05 05 2020
05 05 2020
Historique:
received:
25
03
2020
revised:
02
05
2020
accepted:
04
05
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
24
2
2021
Statut:
epublish
Résumé
Podoplanin (PDPN), a small transmembrane mucin-like glycoprotein, is ectopically expressed. It is also known to be linked with several aspects of tumor malignancy in some types of human tumors, including invasion, metastasis, and cancer stemness. However, there are few reports on the expression of dog PDPN (dPDPN) in canine tumors, and the association between dPDPN and tumor malignancy has not been elucidated. We identified that 11 out of 18 types of canine tumors expressed dPDPN. Furthermore, 80% of canine malignant melanoma (MM), squamous cell carcinoma, and meningioma expressed dPDPN. Moreover, the expression density of dPDPN was positively associated with the expression of the Ki67 proliferation marker. The silencing of dPDPN by siRNAs resulted in the suppression of cell migration, invasion, stem cell-like characteristics, and cell viability in canine MM cell lines. The suppression of cell viability was caused by the induction of apoptosis and G2/M phase cell cycle arrest. Overall, this study demonstrates that dPDPN is expressed in various types of canine tumors and that dPDPN silencing suppresses cell viability through apoptosis and cell cycle arrest, thus providing a novel biological role for PDPN in tumor progression.
Identifiants
pubmed: 32380790
pii: cells9051136
doi: 10.3390/cells9051136
pmc: PMC7290317
pii:
doi:
Substances chimiques
Membrane Glycoproteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest involving this article.
Références
Int J Cancer. 2011 Sep 15;129(6):1404-9
pubmed: 21105028
J Neurosci Res. 2007 Nov 15;85(15):3244-53
pubmed: 17600826
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Dev Dyn. 2008 Mar;237(3):847-57
pubmed: 18265012
Transl Res. 2012 Mar;159(3):165-72
pubmed: 22340765
Int Rev Cell Mol Biol. 2015;317:185-239
pubmed: 26008786
Acta Neuropathol. 2006 Jun;111(6):563-8
pubmed: 16718353
Sci Rep. 2017 Jan 06;7:39971
pubmed: 28059107
J Vet Med Sci. 2016 Oct 1;78(9):1515-1520
pubmed: 27246397
J Vet Med Sci. 2001 Jan;63(1):83-6
pubmed: 11217070
J Cutan Pathol. 2014 Jul;41(7):561-7
pubmed: 24588302
Vet Comp Oncol. 2006 Jun;4(2):104-13
pubmed: 19754820
Hum Pathol. 2005 Apr;36(4):372-80
pubmed: 15891998
Am J Cancer Res. 2016 Jan 15;6(2):370-86
pubmed: 27186410
PLoS One. 2013 Aug 21;8(8):e73609
pubmed: 23991201
J Clin Invest. 2015 Jan;125(1):129-40
pubmed: 25415436
Vet Comp Oncol. 2015 Sep;13(3):288-304
pubmed: 23745794
Vet Surg. 1991 Nov-Dec;20(6):397-401
pubmed: 1369522
J Can Dent Assoc. 2007 May;73(4):339-44
pubmed: 17484800
Oral Dis. 1996 Jun;2(2):148-54
pubmed: 8957928
J Am Vet Med Assoc. 2001 May 1;218(9):1444-8
pubmed: 11345308
Brain Tumor Pathol. 2010 Apr;27(1):23-7
pubmed: 20425044
Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):63-66
pubmed: 29256716
BMC Cancer. 2010 Apr 14;10:140
pubmed: 20398247
Am J Cancer Res. 2015 Jan 15;5(2):514-29
pubmed: 25973294
J Clin Invest. 2005 Oct;115(10):2625-32
pubmed: 16200195
PLoS Genet. 2015 Jun 01;11(6):e1005277
pubmed: 26030765
Arch Immunol Ther Exp (Warsz). 2007 Mar-Apr;55(2):61-75
pubmed: 17347801
Histopathology. 2005 Apr;46(4):396-402
pubmed: 15810951
J Cell Sci. 2006 Nov 1;119(Pt 21):4541-53
pubmed: 17046996
Sci Rep. 2019 Apr 24;9(1):6511
pubmed: 31019223
Mol Ther Oncolytics. 2019 Aug 28;15:49-59
pubmed: 31650025
Mod Pathol. 2008 Feb;21(2):125-30
pubmed: 18084256
Elife. 2016 Jan 14;5:e12994
pubmed: 26765561
PLoS One. 2012;7(7):e41845
pubmed: 22844530
Vet Pathol. 2000 Nov;37(6):597-608
pubmed: 11105949
J Vet Med Sci. 1999 Apr;61(4):361-7
pubmed: 10342286
J Transl Med. 2017 Jul 1;15(1):151
pubmed: 28668095
JCI Insight. 2017 Sep 7;2(17):
pubmed: 28878118
Genes (Basel). 2019 Jun 30;10(7):
pubmed: 31262050
Vet J. 2017 Mar;221:38-47
pubmed: 28283079
J Vet Med Sci. 1998 Jun;60(6):757-60
pubmed: 9673952
Cell Death Differ. 1999 Feb;6(2):99-104
pubmed: 10200555
J Small Anim Pract. 2011 Jul;52(7):359-64
pubmed: 21726228
J Vet Med Sci. 2004 Nov;66(11):1437-40
pubmed: 15585963
Pathol Int. 2010 Mar;60(3):193-202
pubmed: 20403045
Invest Ophthalmol Vis Sci. 2014 Jul 01;55(8):4813-22
pubmed: 24985477
Pathol Int. 2008 Dec;58(12):771-4
pubmed: 19067851
BMC Cancer. 2018 Dec 4;18(1):1219
pubmed: 30514258
Science. 1998 Jan 23;279(5350):509-14
pubmed: 9438836
EMBO J. 2003 Oct 15;22(20):5612-21
pubmed: 14532133
Int J Mol Sci. 2018 Jan 30;19(2):
pubmed: 29385676
PLoS One. 2019 Jun 17;14(6):e0218382
pubmed: 31206526
Oncotarget. 2016 Jun 14;7(24):35592-35606
pubmed: 27232757
J Cell Sci. 2016 Mar 15;129(6):1285
pubmed: 26979625
Cancers (Basel). 2019 Oct 22;11(10):
pubmed: 31652660
Monoclon Antib Immunodiagn Immunother. 2016 Aug;35(4):212-6
pubmed: 27380308
Cancer Sci. 2016 Sep;107(9):1198-205
pubmed: 27294401
Pathol Res Pract. 2011 Feb 15;207(2):111-5
pubmed: 21194851
Cancer Sci. 2018 May;109(5):1292-1299
pubmed: 29575529
Cell Signal. 2013 Oct;25(10):1955-61
pubmed: 23669310
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
Am J Pathol. 2016 Jan;186(1):101-8
pubmed: 26597882
Int J Mol Sci. 2019 Feb 06;20(3):
pubmed: 30736372
Pigment Cell Melanoma Res. 2014 Jan;27(1):37-47
pubmed: 24128326
Cell Death Differ. 2001 Nov;8(11):1052-65
pubmed: 11687884
PLoS One. 2017 Sep 22;12(9):e0184970
pubmed: 28938000
Am J Pathol. 1999 Feb;154(2):385-94
pubmed: 10027397
BMC Cancer. 2019 Jun 17;19(1):599
pubmed: 31208371
Biochem Biophys Res Commun. 2012 May 25;422(1):194-9
pubmed: 22575513
Trends Mol Med. 2011 Jul;17(7):380-8
pubmed: 21439907
Monoclon Antib Immunodiagn Immunother. 2016 Oct;35(5):263-266
pubmed: 27788030
J Am Vet Med Assoc. 2003 May 1;222(9):1234-6
pubmed: 12725311
Front Oncol. 2019 Nov 15;9:1257
pubmed: 31803625
Immunol Rev. 2013 Nov;256(1):255-68
pubmed: 24117826
FEBS Lett. 2008 Jan 23;582(2):341-5
pubmed: 18158922
Vet Sci. 2016 Feb 19;3(1):
pubmed: 29056717
Dev Biol. 2003 Apr 1;256(1):61-72
pubmed: 12654292
Vet Pathol. 2011 Jan;48(1):41-53
pubmed: 21123859
Monoclon Antib Immunodiagn Immunother. 2017 Dec;36(6):291-295
pubmed: 29161183
Int J Clin Exp Pathol. 2015 Jul 01;8(7):8663-70
pubmed: 26339454
Sci Rep. 2017 Feb 08;7:42186
pubmed: 28176852
J Am Acad Dermatol. 2013 Jun;68(6):957-66
pubmed: 23375456
Vet Radiol Ultrasound. 2003 May-Jun;44(3):352-9
pubmed: 12816381
Vet Surg. 1992 Sep-Oct;21(5):337-41
pubmed: 1413465